| Aktie | Ticker | 2026/Q1 | 2025/Q4 | ||||
|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | ||
| 105.625.159 $ | +47.735.929 $ | +7,3 % | 87.455.205 $ | +87.455.205 $ | |||
| BANK OF AMERICA CORP /DE/ | BAC | 17.520.818 $ | +4.581.218 $ | +35,4 % | 12.939.600 $ | +12.939.600 $ | |
| Axsome Therapeutics, Inc. | AXSM | 6.929.820 $ | +6.929.820 $ | ||||
| Xeris Biopharma Holdings, Inc. | XERS | 5.945.000 $ | -335.000 $ | -5,3 % | 6.280.000 $ | +6.280.000 $ | |
| BIOMARIN PHARMACEUTICAL INC | BMRN | 4.632.180 $ | -1.310.820 $ | -22,1 % | 5.943.000 $ | +5.943.000 $ | |
| KalVista Pharmaceuticals, Inc. | KALV | 5.570.978 $ | +5.570.978 $ | ||||
| AMICUS THERAPEUTICS, INC. | FOLD | 5.335.740 $ | +209.340 $ | +4,1 % | 5.126.400 $ | +5.126.400 $ | |
| Verastem, Inc. | VSTM | 4.346.000 $ | +2.261.600 $ | +108,5 % | 2.084.400 $ | +2.084.400 $ | |
| ACADIA PHARMACEUTICALS INC | ACAD | 2.737.980 $ | -1.535.620 $ | -35,9 % | 4.273.600 $ | +4.273.600 $ | |
| Annexon, Inc. | ANNX | 965.345 $ | -2.799.655 $ | -74,4 % | 3.765.000 $ | +3.765.000 $ | |
| Nuvation Bio Inc. | NUVB | 3.584.000 $ | +3.584.000 $ | ||||
| ARROWHEAD PHARMACEUTICALS, INC. | ARWR | 3.470.445 $ | +3.470.445 $ | ||||
| Vaxcyte, Inc. | PCVX | 3.335.514 $ | +1.028.514 $ | +44,6 % | 2.307.000 $ | +2.307.000 $ | |
| Vera Therapeutics, Inc. | VERA | 3.298.860 $ | +3.298.860 $ | ||||
| Travere Therapeutics, Inc. | TVTX | 3.288.897 $ | +3.288.897 $ | ||||
| MoonLake Immunotherapeutics | MLTX | 3.248.020 $ | +3.248.020 $ | ||||
| Zentalis Pharmaceuticals, Inc. | ZNTL | 2.878.200 $ | +1.096.200 $ | +61,5 % | 1.782.000 $ | +1.782.000 $ | |
| Scholar Rock Holding Corp | SRRK | 2.821.784 $ | +2.821.784 $ | ||||
| BridgeBio Pharma, Inc. | BBIO | 2.753.640 $ | +2.753.640 $ | ||||
| PTC THERAPEUTICS, INC. | PTCT | 698.333 $ | -2.036.227 $ | -74,5 % | 2.734.560 $ | +2.734.560 $ | |
| ARDELYX, INC. | ARDX | 2.701.490 $ | +2.701.490 $ | ||||
| UNITED THERAPEUTICS Corp | UTHR | 2.679.875 $ | +2.679.875 $ | ||||
| BIOCRYST PHARMACEUTICALS INC | BCRX | 2.340.000 $ | +2.340.000 $ | ||||
| Mineralys Therapeutics, Inc. | MLYS | 2.221.380 $ | +2.221.380 $ | ||||
| GENMAB A/S | GMAB | 2.200.060 $ | +44.060 $ | +2,0 % | 2.156.000 $ | +2.156.000 $ | |
| DBV Technologies S.A. | DBVT | 2.141.225 $ | +2.141.225 $ | ||||
| Syndax Pharmaceuticals Inc | SNDX | 2.101.000 $ | +2.101.000 $ | ||||
| CATALYST PHARMACEUTICALS, INC. | CPRX | 2.030.320 $ | +2.030.320 $ | ||||
| Sionna Therapeutics, Inc. | SION | 1.972.428 $ | +1.972.428 $ | ||||
| Tarsus Pharmaceuticals, Inc. | TARS | 1.965.120 $ | +1.965.120 $ | ||||
| APOGEE ENTERPRISES, INC. | APOG | 1.887.000 $ | +1.887.000 $ | ||||
| Contineum Therapeutics, Inc. | CTNM | 1.854.520 $ | +1.854.520 $ | ||||
| INSMED Inc | INSM | 1.740.400 $ | +1.740.400 $ | ||||
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | 1.695.709 $ | +1.695.709 $ | ||||
| LIGAND PHARMACEUTICALS INC | LGND | 1.637.130 $ | +1.637.130 $ | ||||
| Edgewise Therapeutics, Inc. | EWTX | 1.549.800 $ | +110.530 $ | +7,7 % | 1.439.270 $ | +1.439.270 $ | |
| CORCEPT THERAPEUTICS INC | CORT | 1.531.200 $ | +1.531.200 $ | ||||
| Immatics N.V. | IMTX | 1.512.900 $ | +672.900 $ | +80,1 % | 840.000 $ | +840.000 $ | |
| Silence Therapeutics plc | SLN | 740.435 $ | -718.765 $ | -49,3 % | 1.459.200 $ | +1.459.200 $ | |
| LEXICON PHARMACEUTICALS, INC. | LXRX | 1.407.120 $ | +395.120 $ | +39,0 % | 1.012.000 $ | +1.012.000 $ | |
| Beam Therapeutics Inc. | BEAM | 1.367.842 $ | -18.158 $ | -1,3 % | 1.386.000 $ | +1.386.000 $ | |
| Oric Pharmaceuticals, Inc. | ORIC | 1.298.675 $ | -10.125 $ | -0,8 % | 1.308.800 $ | +1.308.800 $ | |
| Apellis Pharmaceuticals, Inc. | APLS | 1.256.000 $ | +1.256.000 $ | ||||
| NewAmsterdam Pharma Co N.V. | NAMS | 1.181.169 $ | +128.769 $ | +12,2 % | 1.052.400 $ | +1.052.400 $ | |
| Denali Therapeutics Inc. | DNLI | 1.155.700 $ | +1.155.700 $ | ||||
| Ascendis Pharma A/S | ASND | 1.066.200 $ | +1.066.200 $ | ||||
| Biohaven Ltd. | BHVN | 993.520 $ | +993.520 $ | ||||
| Dianthus Therapeutics, Inc. /DE/ | DNTH | 989.040 $ | +989.040 $ | ||||
| NEKTAR THERAPEUTICS | NKTR | 845.600 $ | +845.600 $ | ||||
| IDEAYA Biosciences, Inc. | IDYA | 819.672 $ | +819.672 $ | ||||
| AGIOS PHARMACEUTICALS, INC. | AGIO | 816.600 $ | +816.600 $ | ||||
| Immunovant, Inc. | IMVT | 762.600 $ | +762.600 $ | ||||
| Olema Pharmaceuticals, Inc. | OLMA | 750.000 $ | +750.000 $ | ||||
| Arcutis Biotherapeutics, Inc. | ARQT | 348.480 $ | +348.480 $ | ||||
| Gossamer Bio, Inc. | GOSS | 269.370 $ | +269.370 $ | ||||
| 105.625.159 $ | +47.735.929 $ | +7,3 % | 87.455.205 $ | +87.455.205 $ | |||